skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > benzodiazepine > (s)-3,4-dihydro-3-(1h-indol-3-ylmethyl)-4-methyl-1h-1,4-benzodiazepine-2,5-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > benzodiazepine > (s)-3,4-dihydro-3-(1h-indol-3-ylmethyl)-4-methyl-1h-1,4-benzodiazepine-2,5-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > benzodiazepine > (s)-3,4-dihydro-3-(1h-indol-3-ylmethyl)-4-methyl-1h-1,4-benzodiazepine-2,5-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > benzodiazepine > (s)-3,4-dihydro-3-(1h-indol-3-ylmethyl)-4-methyl-1h-1,4-benzodiazepine-2,5-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > benzodiazepine > (s)-3,4-dihydro-3-(1h-indol-3-ylmethyl)-4-methyl-1h-1,4-benzodiazepine-2,5-dione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > benzodiazepine > (s)-3,4-dihydro-3-(1h-indol-3-ylmethyl)-4-methyl-1h-1,4-benzodiazepine-2,5-dione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > benzodiazepine > (s)-3,4-dihydro-3-(1h-indol-3-ylmethyl)-4-methyl-1h-1,4-benzodiazepine-2,5-dione

Preferred term

(s)-3,4-dihydro-3-(1h-indol-3-ylmethyl)-4-methyl-1h-1,4-benzodiazepine-2,5-dione  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C19H17N3O2

inchi

  • InChI=1S/C19H17N3O2/c1-22-17(10-12-11-20-15-8-4-2-6-13(12)15)18(23)21-16-9-5-3-7-14(16)19(22)24/h2-9,11,17,20H,10H2,1H3,(H,21,23)/t17-/m0/s1

inchikey

  • QYBGEUDXQJVALS-KRWDZBQOSA-N

mass

  • 319.364

monoisotopicmass

  • 319.13208

smiles

  • O=C1N([C@H](C(=O)NC2=C1C=CC=C2)CC=3C4=C(C=CC=C4)NC3)C

subset

  • 2_STAR

synonym EXACT

  • (3S)-3-(1H-indol-3-ylmethyl)-4-methyl-1,3-dihydro-1,4-benzodiazepine-2,5-dione

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:227037

Download this concept:

RDF/XML TURTLE JSON-LD